Evidence map›Paper›PMID 38988458›Full record

ArticleFocus (American Psychiatric Publishing)2024

Innovative and Emerging Treatments for Anorexia Nervosa.

Amanda E Downey, Sasha Gorrell

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Focus (American Psychiatric Publishing), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amanda E DowneyDepartment of Pediatrics (Downey) and Department of Psychiatry and Behavioral Sciences (both authors), University of California, San Francisco.
Sasha GorrellDepartment of Pediatrics (Downey) and Department of Psychiatry and Behavioral Sciences (both authors), University of California, San Francisco.

Funding

UCSD Leading the Advancement of Underrepresented Neuroscientists for Change (LAUNCH) Faculty Development ProgramR25NS117367 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Victoria B Risbrough, Joann Trejo · 2020 to 2026
$1.6M
Neural Correlates of Reinforcement Learning Specific to Hyperactivityin Adolescent Anorexia NervosaK23MH126201 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GORRELL, SASHA CATHERINE · 2021 to 2025
$848k
Characterizing Acute Exercise Response in Restrictive Eating DisordersR21MH131787 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI GORRELL, SASHA CATHERINE, SCHAUMBERG, KATHERINE · 2023 to 2023
$450k
NIMH NIH HHS K23 MH126201NIMH NIH HHS R21 MH131787NINDS NIH HHS R25 NS117367
6 · The paper itself

Abstract

Unlike psychopharmacologic interventions for other psychiatric conditions, few medications have emerged as helpful in improving eating disorder cognitions and evidence-based psychotherapies fail many patients. Novel treatments are urgently needed to address anorexia nervosa (AN), which is increasingly prevalent and difficult to treat. This article provides an overview of preliminary investigations into cannabidiol, psilocybin therapy, ketamine and the ketogenic diet, transcranial magnetic stimulation, and vagus nerve stimulation in individuals with AN. These pilot studies underscore the need for larger clinical trials that include more participant diversity in order to rapidly translate findings to real-world clinical practice.

Indexed as

Anorexia NervosaClinical ResearchFeeding and Eating DisordersPsychedelic Therapy

Identifiers

PMID38988458
PMCPMC11231466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.